Wednesday, March 11, 2015 10:08:07 PM
Alert
Endocan Corporation (USOTC:ENDO)
Historical Stock Chart
2 Years : From Mar 2013 to Mar 2015
COLORADO SPRINGS, Colo., Feb. 3, 2014 /PRNewswire/ -- Endocan Corporation (NASDAQ OTC: ENDO), a U.S. Company specializing in cannabis and cannabinoid formulation-based health and wellness solutions, provides shareholder guidance concerning its consultant MDS, a subsidiary of Medbox, Inc., and the multi-million dollar agreement for multi-state product release licensing, medical cannabis dispensary management, and cultivation.
"We are excited by the renewed energy with MDS. Endocan looks forward to moving forward with the executives at MDS as an industry leader in consulting and helping match entrepreneurs with opportunities," stated Robert Kane, CFO and SR VP of Business Development, Endocan Corporation. "Endocan is positioned well to take advantage of these opportunities."
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM